Remove 2021 Remove Adverse Reactions Remove Immunization
article thumbnail

EC approves Libtayo® for metastatic cervical cancer

European Pharmaceutical Review

In March 2021, the trial was halted early due to highly significant overall survival (OS) rates in squamous cell carcinoma (SCC) patients. Immune-mediated adverse reactions (ARs) occurred in 21 percent of patients treated with Libtayo ® and led to permanent discontinuation in 4.6 percent), immune-mediated hepatitis (2.4

article thumbnail

The 5 Stages of Hashimoto’s Thyroiditis

The Thyroid Pharmacist

This means that our immune system recognizes the thyroid gland as a foreign invader and begins to attack it, eventually leading to the destruction of our thyroid tissue. Left unbalanced, the immune system may go on to attack different parts of the body, leading to the development of other autoimmune conditions.

Immunity 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BMS Submits Application for Abecma® for Relapsed or Refractory Multiple Myeloma

LifeProNow

Overseas, in the United States, Abecma was approved in March 2021 for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

article thumbnail

The 7 Most Common Nutrient Deficiencies in Hashimoto’s

The Thyroid Pharmacist

Most people with Hashimoto’s have deficiencies in these nutrients, and I’ve seen very limited adverse reactions with supplementation (please check the special considerations/cautions sections under each supplement heading to learn about adverse reactions). (12-16). When to Expect to See Benefits: Usually 3 to 5 days.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

This is especially important due to the two unique toxicities of CAR T cells, namely CRS and the neurology toxicities that subsequently received the term immune effector cell- associated neurotoxicity syndrome (ICANS). After this incident CAR-related toxicity scales and guidelines were established to prevent adverse reactions.

article thumbnail

Innovation in immuno-oncology: Leading companies in oncolytic viral proteins

Pharmaceutical Technology

A major strategy for OV development is genetic manipulation to weaken virus pathogenicity, enhance target selectivity, reduce adverse reactions, and/or insert exogenous therapeutic genes into the virus genome. OVs can be attenuated natural viruses or recombinant viruses.

article thumbnail

The Fundamental Gut Health Protocol

The Thyroid Pharmacist

The gut performs the all-important role of digesting and absorbing the nutrients we take in, but it is also responsible for helping the immune system recognize foreign invaders from self-antigens, thereby facilitating the control of pathogens and preventing autoimmune reactions. And for good reason! Systemic Enzymes. And the best part?